An estimated five to eight percent of people in Germany suffer from an autoimmune disease such as asthma, rheumatoid arthritis, or inflammatory bowel disease. Developing new drugs to treat these conditions is a lengthy and complex process. To significantly accelerate research, Markus Rehberg works a...
